Tirzepatide vs. Semaglutide: How to Choose the Right GLP-1 Medication

With two highly effective GLP-1 medications now available for weight management, many patients wonder which one is the better choice. Both semaglutide and tirzepatide have shown impressive results in clinical trials, but they work in slightly different ways. This guide breaks down the key differences so you can have an informed conversation with your clinician.

How They Work Differently

Semaglutide targets the GLP-1 receptor, which helps regulate appetite and blood sugar. Tirzepatide goes a step further by targeting both GLP-1 and GIP receptors, making it a dual-action medication. This dual mechanism may explain why tirzepatide has shown slightly higher average weight loss in head-to-head comparisons.

Weight Loss Results Compared

In clinical trials, semaglutide helped patients lose an average of about 15% of their body weight. Tirzepatide trials showed even higher numbers, with some participants losing over 20% of their body weight. However, individual results vary based on starting weight, lifestyle factors, and how well you respond to the medication.

Side Effect Profiles

Both medications share similar side effects, primarily gastrointestinal symptoms like nausea, constipation, and occasional diarrhea. These are usually most noticeable in the early weeks and tend to improve as your body adjusts. Tirzepatide may cause slightly more GI discomfort at higher doses, but gradual dose titration helps minimize this for most patients.

Cost and Availability

Brand-name versions of both medications can be expensive without insurance. Compounded versions are available through licensed pharmacies at lower price points, making them more accessible for many patients. Through telehealth, you can discuss both branded and compounded options with your clinician to find the best fit for your budget.

Making Your Decision

The best medication for you depends on your health history, weight-loss goals, budget, and how your body responds. Many clinicians start with semaglutide and consider tirzepatide if results plateau or if the patient is a strong candidate for the dual-action approach. Either way, both are clinically proven tools that work best when combined with healthy habits.